{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:38:39Z","timestamp":1790354319798,"version":"4.1.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1093\/ndt\/gfl062","type":"journal-article","created":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T21:23:00Z","timestamp":1141766580000},"page":"1876-1882","source":"Crossref","is-referenced-by-count":32,"title":["Vascular diseases and their risk factors in IgA nephropathy"],"prefix":"10.1093","volume":"21","author":[{"given":"Juhani","family":"Myllym\u00e4ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Helin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Pasternack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kattainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,3,7]]},"reference":[{"key":"key\n\t\t\t\t20171012195713_BIB1","unstructured":"Mustonen J, Syrj\u00e4nen J, Rantala I, Pasternack A. Clinical course and treatment of IgA nephropathy. J Nephrol2001; 14: 440\u2013446"},{"key":"key\n\t\t\t\t20171012195713_BIB2","doi-asserted-by":"crossref","unstructured":"Mathur S, Devaraj S, Jialal I. Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease. Curr Opin Nephrol Hypertens2002; 11: 141\u2013147","DOI":"10.1097\/00041552-200203000-00003"},{"key":"key\n\t\t\t\t20171012195713_BIB3","doi-asserted-by":"crossref","unstructured":"Weinstock Brown W, Keane WF. Proteinuria and cardiovascular disease. Am J Kidney Dis2001: 38 [Suppl 1]: S8\u2013S13","DOI":"10.1053\/ajkd.2001.27383"},{"key":"key\n\t\t\t\t20171012195713_BIB4","unstructured":"Aromaa A, Koskinen S, eds. Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Publications of the National Public Health Institute B12\/2004. Available at ww.ktl.fi\/terveys2000\/index.uk.html"},{"key":"key\n\t\t\t\t20171012195713_BIB5","doi-asserted-by":"crossref","unstructured":"Myllym\u00e4ki J, Honkanen T, Syrj\u00e4nen J et al. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant2005; 201: 89\u201395","DOI":"10.1093\/ndt\/gfh584"},{"key":"key\n\t\t\t\t20171012195713_BIB6","unstructured":"Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol1998; 11: 239\u2013245"},{"key":"key\n\t\t\t\t20171012195713_BIB7","unstructured":"Crook ED, Washington DO. Addressing cardiovascular disease in patients with renal disease. Ethn Dis2002; 12 [Suppl 3]: S1\u2013S4"},{"key":"key\n\t\t\t\t20171012195713_BIB8","unstructured":"Wallen MD, Radhakrishnan J, Appel G, Hodgson ME, Pablos-Mendez A. An analysis of cardiac mortality in patients with new-onset end-stage renal disease in New York State. Clin Nephrol2001; 55: 101\u2013108"},{"key":"key\n\t\t\t\t20171012195713_BIB9","doi-asserted-by":"crossref","unstructured":"Sacco RL. Newer risk factors for stroke. Neurology2001; 57 [Suppl 2]: S31\u2013S34","DOI":"10.1212\/WNL.57.suppl_2.S31"},{"key":"key\n\t\t\t\t20171012195713_BIB10","doi-asserted-by":"crossref","unstructured":"Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA1996; 275: 1571\u20131576","DOI":"10.1001\/jama.275.20.1571"},{"key":"key\n\t\t\t\t20171012195713_BIB11","doi-asserted-by":"crossref","unstructured":"Donnan GA, Davis SM, Thrift A. The role of blood pressure lowering before and after stroke. Curr Opin Neurol2003; 16: 81\u201386","DOI":"10.1097\/00019052-200302000-00011"},{"key":"key\n\t\t\t\t20171012195713_BIB12","doi-asserted-by":"crossref","unstructured":"Ruilope LM. The kidney as a sensor of cardiovascular risk in essential hypertension. J Am Soc Nephrol2002; 13 [Suppl 3]: S165\u2013S168","DOI":"10.1097\/01.ASN.0000034496.63958.F8"},{"key":"key\n\t\t\t\t20171012195713_BIB13","doi-asserted-by":"crossref","unstructured":"Syrj\u00e4nen J, Mustonen J, Pasternack A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant2000; 15: 34\u201342","DOI":"10.1093\/ndt\/15.1.34"},{"key":"key\n\t\t\t\t20171012195713_BIB14","doi-asserted-by":"crossref","unstructured":"Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk1996: 3: 213\u2013219","DOI":"10.1097\/00043798-199604000-00014"},{"key":"key\n\t\t\t\t20171012195713_BIB15","doi-asserted-by":"crossref","unstructured":"Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Int Med1999; 131: 7\u201313","DOI":"10.7326\/0003-4819-131-1-199907060-00003"},{"key":"key\n\t\t\t\t20171012195713_BIB16","doi-asserted-by":"crossref","unstructured":"Orth S. Smoking\u2014a renal risk factor. Nephron2000; 86: 12\u201326","DOI":"10.1159\/000045708"},{"key":"key\n\t\t\t\t20171012195713_BIB17","doi-asserted-by":"crossref","unstructured":"Wakai K, Kawamura T, Matsuo S, Hotta N, Ohno Y. Risk factors for IgA nephropathy: a case-control study in Japan. Am J Kidney Dis1999; 33: 738\u2013745","DOI":"10.1016\/S0272-6386(99)70228-3"},{"key":"key\n\t\t\t\t20171012195713_BIB18","doi-asserted-by":"crossref","unstructured":"Galle J, Heermeier K, Wanner C. Atherogenic lipoproteins, oxidative stress, and cell death. Kidney Int1999; 56 [Suppl 71]: S62\u2013S66","DOI":"10.1046\/j.1523-1755.1999.07116.x"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/7\/1876\/5156726\/gfl062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T02:49:30Z","timestamp":1555469370000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/7\/1876\/1821808\/Vascular-diseases-and-their-risk-factors-in-IgA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,7]]},"references-count":18,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2006,3,7]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfl062","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,3,7]]}}}